Jocelyn Solis-Moreira

Jocelyn Solis-Moreira

Feature Writer

B.Sc. Integrative Neuroscience, M.Sc. Psychology

Jocelyn Solis-Moreira graduated with a Bachelor's in Integrative Neuroscience, where she then pursued graduate research looking at the long-term effects of adolescent binge drinking on the brain's neurochemistry in adulthood. She is adept at translating and summarizing complex study findings in all medical fields with a particular interest in neurodegenerative diseases, cancer research, infectious diseases, and public health. As a freelance writer, her work spans from news articles and feature articles to evergreen explainers across many publications. Her overall goal is to make science accessible for all.

Articles from Jocelyn

Patients on dialysis show reduced antibody levels four months after COVID-19 vaccination

Patients on dialysis show reduced antibody levels four months after COVID-19 vaccination

Study suggests algorithm may help optimize future COVID-19 vaccine design

Study suggests algorithm may help optimize future COVID-19 vaccine design

Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels

Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

Study suggests Harmony COVID-19 assay is superior to laboratory-based tests

Study suggests Harmony COVID-19 assay is superior to laboratory-based tests

SARS-CoV-2 Delta variant: A gloomy forecast for the United States

SARS-CoV-2 Delta variant: A gloomy forecast for the United States

Study finds high risk groups rejecting the COVID-19 vaccine in England

Study finds high risk groups rejecting the COVID-19 vaccine in England

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

In Australia, high vaccine hesitancy among most vulnerable to COVID-19

How does the mRNA/lipid nanoparticle platform promote protective adaptive immunity against SARS-CoV-2?

How does the mRNA/lipid nanoparticle platform promote protective adaptive immunity against SARS-CoV-2?

Could a plant metabolite in liverworts be a potent antiviral against SARS-CoV-2 and other RNA viruses?

Could a plant metabolite in liverworts be a potent antiviral against SARS-CoV-2 and other RNA viruses?